Losartan-Antioxidant Hybrids: Novel Molecules for the Prevention of Hypertension-Induced Cardiovascular Damage
Authors:
- 28 October 2009
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 52 (22) , 7220-7227
Abstract
We report the first examples of a new series of antioxidant-sartan hybrids (AO-sartans), which were made by adding an antioxidant fragment to the hydroxymethyl side chain of losartan. Experiments performed in cultured cells demonstrate that these new hybrids retain the ability to block the angiotensin II effect with increased antioxidant ability. In hypertensive rats, these compounds show properties that suggest they may be more useful than losartan for controlling hypertension and preventing hypertension-induced cardiovascular damage.Keywords
This publication has 23 references indexed in Scilit:
- New NO-Releasing Pharmacodynamic Hybrids of Losartan and Its Active Metabolite: Design, Synthesis, and Biopharmacological PropertiesJournal of Medicinal Chemistry, 2006
- Oxidized LDL induces mitochondrially associated reactive oxygen/nitrogen species formation in endothelial cellsAmerican Journal of Physiology-Heart and Circulatory Physiology, 2005
- Role of Oxidative Modifications in AtherosclerosisPhysiological Reviews, 2004
- Angiotensin II-Mediated Development of Vascular DiseasesTrends in Cardiovascular Medicine, 2004
- Diabetes Mellitus Enhances Vascular Matrix Metalloproteinase ActivityCirculation Research, 2001
- Endothelial Dysfunction in Cardiovascular Diseases: The Role of Oxidant StressCirculation Research, 2000
- Reactive Oxygen Species Mediate the Activation of Akt/Protein Kinase B by Angiotensin II in Vascular Smooth Muscle CellsJournal of Biological Chemistry, 1999
- Differential Effect of Hydrogen Peroxide and Superoxide Anion on Apoptosis and Proliferation of Vascular Smooth Muscle CellsCirculation, 1997
- Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular matrix metalloproteinases in vitro. Implications for atherosclerotic plaque stability.Journal of Clinical Investigation, 1996
- Nonpeptide Angiotensin II Receptor Antagonists: The Next Generation in Antihypertensive TherapyJournal of Medicinal Chemistry, 1996